newsfilter
← Latest News
GlobeNewswire·

Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments

Proposed combination with Clywedog Therapeutics Inc. ("Clywedog") to create a differentiated company focusing on clinical metabolic and autoimmune pipeline assets and to build on the Company's base of high caliber